Your browser doesn't support javascript.
loading
Haplotype-aware analysis of somatic copy number variations from single-cell transcriptomes.
Gao, Teng; Soldatov, Ruslan; Sarkar, Hirak; Kurkiewicz, Adam; Biederstedt, Evan; Loh, Po-Ru; Kharchenko, Peter V.
Afiliação
  • Gao T; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Soldatov R; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Sarkar H; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Kurkiewicz A; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Biederstedt E; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Loh PR; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Kharchenko PV; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Nat Biotechnol ; 41(3): 417-426, 2023 03.
Article em En | MEDLINE | ID: mdl-36163550
ABSTRACT
Genome instability and aberrant alterations of transcriptional programs both play important roles in cancer. Single-cell RNA sequencing (scRNA-seq) has the potential to investigate both genetic and nongenetic sources of tumor heterogeneity in a single assay. Here we present a computational method, Numbat, that integrates haplotype information obtained from population-based phasing with allele and expression signals to enhance detection of copy number variations from scRNA-seq. Numbat exploits the evolutionary relationships between subclones to iteratively infer single-cell copy number profiles and tumor clonal phylogeny. Analysis of 22 tumor samples, including multiple myeloma, gastric, breast and thyroid cancers, shows that Numbat can reconstruct the tumor copy number profile and precisely identify malignant cells in the tumor microenvironment. We identify genetic subpopulations with transcriptional signatures relevant to tumor progression and therapy resistance. Numbat requires neither sample-matched DNA data nor a priori genotyping, and is applicable to a wide range of experimental settings and cancer types.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transcriptoma / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transcriptoma / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article